5 questions on CRISPR-Cas with Sandeep Rajan

2026-09-01T08:46:22+01:001 September 2026|

From bacterial defence to breakthrough therapies, we explore how CRISPR-Cas is transforming research and healthcare, and how experts at the Wellcome Sanger Institute are refining the technology to make genome editing more scalable and effective.

A living library: Inside our organoid biobank

2026-08-05T16:12:36+01:005 August 2026|

Tiny organs, big story. We explore how our organoid biobank came to life – from building long-lived models to making data openly available to the research community.

From bases to breakthroughs: Editing cancer’s weak spots with CRISPR

2026-05-26T13:53:09+01:0026 May 2026|

In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founder of BASE Rx alongside Group Leader, Dr Mathew Garnett.

Mosaic’s becoming

2024-07-05T10:46:37+01:0012 September 2023|

The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.